LSL Pharma Group Inc. (TSXV:LSL)
Canada · Delayed Price · Currency is CAD 0.3600
+0.0200 (5.88%)
At close: Dec 19, 2025
LSL Pharma Group Market Cap
LSL Pharma Group has a market cap or net worth of CAD 43.64 million as of December 19, 2025. Its market cap has decreased by -14.15% in one year.
Market Cap
43.64M
Enterprise Value
65.24M
Revenue
26.80M
Ranking
n/a
PE Ratio
15.87
Stock Price
0.36
Market Cap Chart
Since March 2, 2023, LSL Pharma Group's market cap has decreased from 61.67M to 43.64M, a decrease of -29.24%. That is a compound annual growth rate of -11.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 43.64M | -7.87% |
| Dec 31, 2024 | 47.37M | 18.48% |
| Dec 29, 2023 | 39.98M | -35.17% |
| Mar 2, 2023 | 61.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.20B |
| Green Thumb Industries | 2.61B |
| dentalcorp Holdings | 2.18B |
| Extendicare | 2.08B |
| Sienna Senior Living | 2.00B |
| Trulieve Cannabis | 1.97B |
| Cronos Group | 1.55B |
| WELL Health Technologies | 990.54M |